As a STAT+ subscriber, you can go beyond the paywall to access STAT's award winning journalism, special discounts on STAT Events and Reports, complimentary access to premium data tools, and must-read subscriber-only newsletters. Don't miss out on these invaluable benefits!
Dive into STAT's in-depth report on how artificial intelligence is reshaping medicine and life sciences. Discover its transformative potential, from streamlining hospital operations to revolutionizing drug development while addressing critical risks like bias and privacy concerns. Gain insights into regulatory debates and meet the visionaries shaping AI's role in health care.
STAT+ subscribers receive 20% off all STAT Reports.
Relive this year's J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for the year ahead.
Precision medicine, targeted treatments, and actionable biomarker testing are transforming the treatment landscape for breast cancer. In this STAT Brand Studio virtual event, one clinical expert addresses existing challenges in the second-line treatment setting for patients with HR+/HER2- locally advanced or metastatic breast cancer. She also shares how the latest advances have the potential to help redefine the treatment paradigm for patients with qualifying alterations who experience tumor progression on, or resistance to widely used first-line therapies.
No comments